Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher comp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Mitchell R., Neuberg, Donna, Flinn, Ian W., Grever, Michael R., Lazarus, Hillard M., Rowe, Jacob M., Dewald, Gordon, Bennett, John M., Paietta, Elisabeth M., Byrd, John C., Hussein, Mohamad A., Appelbaum, Frederick R., Larson, Richard A., Litzow, Mark R., Tallman, Martin S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186330/
https://ncbi.nlm.nih.gov/pubmed/21803850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-03-342485
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados